Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
Canada
Politics
World
En français
Sports
Business
Lifestyle
AI
Tech
Science

"AbbVie"
Topics

Advertisement

Advertisement

"AbbVie"

Showing articles that match "AbbVie" in the headline

In the last 2 hours

AbbVie wins EU approval for paediatric pJIA use PharmaTimes 11:49

In the last 4 hours

AbbVie Presents Detailed Phase 1 Data for ABBV-295, a Long-Acting Amylin Analog, Demonstrating Favorable Tolerability and Pharmacokinetic Profile at Easd 2026 PR Newswire (Press Release) 10:48

In the last 6 hours

AbbVie Reports Positive Phase 2 Results For Zumilokibart In Atopic Dermatitis RTT News 08:08

Advertisement

Advertisement

In the last 8 hours

AbbVie Highlights Positive Results from the Phase 2 apex Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at Eadv 2026 PR Newswire (Press Release) 06:33

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 Eadv Congress PR Newswire (Press Release) 06:02

Yesterday

AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks 23:50 Tue, 29 Sep

AbbVie Wins FDA Nod for New Parkinson's Disease Drug Juvmo Zacks 18:44 Tue, 29 Sep

UnitedHealth, AbbVie And A Health Care Stock On CNBC’s ‘Final Trades’ Benzinga 15:49 Tue, 29 Sep

AbbVie Partners with Valkai to Apply Advanced AI Across Targeted Areas of Clinical Development PR Newswire (Press Release) 14:04 Tue, 29 Sep

Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium Business Wire (Press Release) 13:04 Tue, 29 Sep

The Zacks Analyst Blog Highlights Alphabet, Mastercard, AbbVie, Perma-Pipe and ImmuCell Zacks 09:31 Tue, 29 Sep

AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trials Medical Daily 05:26 Tue, 29 Sep

Monday

Top Research Reports for Alphabet, Mastercard & AbbVie Zacks 22:59 Mon, 28 Sep

AbbVie’s Juvmo Approval Adds More Fuel For Neuroscience Portfolio Growth Scrip Pharma Intelligence 22:49 Mon, 28 Sep

Abbvie’s Juvmo FDA approval brings new Parkinson’s option BioWorld 22:34 Mon, 28 Sep

AbbVie Wins FDA Approval For Juvmo In Parkinson's Disease RTT News 17:37 Mon, 28 Sep

AbbVie wins FDA nod for Parkinson’s pill STAT 14:44 Mon, 28 Sep

Advertisement

AbbVie Announces FDA Approval Of Juvmo For Parkinson's Disease RTT News 13:32 Mon, 28 Sep

AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo Pharmaceutical Technology 13:22 Mon, 28 Sep

U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease AbbVie (Press Release) 13:04 Mon, 28 Sep

AbbVie's Cerevel takeover delivers Parkinson's approval pharmaphorum 11:24 Mon, 28 Sep

Saturday

AbbVie Has Access In Mind With Myeloma Trispecific Antibody ABBV-2001 Scrip Pharma Intelligence 09:44 Sat, 26 Sep

AbbVie Says Botox Exempt From Medicare Price Negotiations Law360 00:38 Sat, 26 Sep

Friday

AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026? The Motley Fool 22:13 Fri, 25 Sep

Thursday

AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? The Motley Fool 22:28 Thu, 24 Sep

AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026? The Motley Fool 21:27 Thu, 24 Sep

UChicago Medicine completes construction phase of AbbVie Foundation Cancer Pavilion, bringing new era of cancer care closer to reality PR Newswire (Press Release) 20:10 Thu, 24 Sep

Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick? Zacks 17:54 Thu, 24 Sep

Beyond Imbruvica: Can AbbVie Rebuild Its Oncology Portfolio? Zacks 17:13 Thu, 24 Sep

AbbVie (ABBV) Expands AI Drug Discovery With New Partnerships And Industry Initiative Simply Wall St 15:03 Thu, 24 Sep

AbbVie's Epkinly Receives Health Canada Approval For Follicular Lymphoma RTT News 13:00 Thu, 24 Sep

Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade The Motley Fool 05:42 Thu, 24 Sep

In the last month

AbbVie's Rinvoq Wins EU Approval in Juvenile Idiopathic Arthritis Zacks 18:26 Tue, 22 Sep

AbbVie Participates in USTR’s Section 301 Investigation into Germany to Address Global Imbalances in How Transformative Medicines are Valued AbbVie (Press Release) 17:29 Tue, 22 Sep

Iambic files IPO after signing up AbbVie as new partner pharmaphorum 11:58 Tue, 22 Sep

AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September? The Motley Fool 11:31 Tue, 22 Sep

AbbVie Secures EU Approval For Rinvoq In Children With Juvenile Arthritis RTT News 09:37 Tue, 22 Sep

AbbVie Announces European Commission Approval of Rinvoq® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis PR Newswire (Press Release) 07:06 Tue, 22 Sep

AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery PR Newswire (Press Release) 13:00 Mon, 21 Sep

AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now? The Motley Fool 20:34 Sat, 19 Sep

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Canada Canada
Politics Politics
World World
En français
Sports Sports
Business Business
Lifestyle Lifestyle
AI AI
Tech Tech
Science Science